Mike Ufer Selected Research

selatogrel

4/2020	Absorption, distribution, metabolism and excretion of the P2Y12 receptor antagonist selatogrel after subcutaneous administration in healthy subjects.
1/2020	Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.
1/2020	Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mike Ufer Research Topics

Disease

5	Hemorrhage 01/2020 - 01/2005
3	Myocardial Infarction 04/2020 - 01/2020
2	Obstructive Sleep Apnea 01/2022 - 11/2021
2	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2021 - 02/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 08/2020
2	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 11/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2007
2	Breast Neoplasms (Breast Cancer) 04/2012 - 07/2010
2	Epilepsy (Aura) 10/2011 - 05/2009
1	Apnea 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Conjunctivitis 01/2021
1	Anemia 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Nausea 01/2020
1	Intracranial Vasospasm 01/2020
1	Vomiting 01/2020
1	Asymptomatic Diseases 11/2018
1	Amyloid Plaque 11/2018
1	Dementia (Dementias) 11/2018
1	Human Influenza (Influenza) 11/2017
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2014
1	Partial Epilepsies (Epilepsy, Partial) 10/2011
1	Hyperalgesia 03/2011
1	Neuralgia (Stump Neuralgia) 03/2011
1	Folic Acid Deficiency (Folic Acid Deficiencies) 02/2010
1	Ulcerative Colitis 12/2009
1	Drug Resistant Epilepsy 05/2009
1	Febrile Seizures (Febrile Seizure) 05/2009
1	Thromboembolism 01/2005
1	Drug-Related Side Effects and Adverse Reactions 03/2004
1	Atrial Fibrillation 01/2004
1	Thrombophlebitis 01/2004
1	Pulmonary Embolism 01/2004

Drug/Important Bio-Agent (IBA)

5	daridorexantIBA 01/2022 - 02/2019
5	Orexin Receptor AntagonistsIBA 01/2022 - 02/2019
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
3	Purinergic P2Y Receptor AntagonistsIBA 04/2020 - 01/2020
3	selatogrelIBA 04/2020 - 01/2020
3	Endothelin A ReceptorIBA 01/2020 - 01/2019
3	clazosentanIBA 01/2020 - 01/2019
2	cenerimodIBA 01/2021 - 08/2020
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2021 - 08/2020
2	UmibecestatIBA 11/2020 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 12/2009
2	EnzymesIBA 04/2012 - 07/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 07/2010
2	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 07/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2012 - 07/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2011 - 05/2009
2	Vitamin K FDA Link 03/2010 - 01/2005
2	Warfarin (Coumadin)FDA LinkGeneric 03/2010 - 02/2010
1	Amyloid beta-PeptidesIBA 11/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	TicagrelorIBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	PotassiumIBA 01/2020
1	Prasugrel Hydrochloride FDA Link 01/2020
1	Amyloid (Amyloid Fibrils)IBA 11/2018
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 11/2017
1	siponimodIBA 11/2017
1	AntigensIBA 11/2017
1	Immunoglobulins (Immunoglobulin)IBA 11/2017
1	VaccinesIBA 11/2017
1	mavoglurantIBA 01/2014
1	hydroxide ionIBA 04/2012
1	AnkyrinsIBA 03/2011
1	Transient Receptor Potential ChannelsIBA 03/2011
1	Phenytoin (Dilantin)FDA LinkGeneric 02/2010
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2010
1	hydroxyphenytoinIBA 02/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2010
1	CytokinesIBA 12/2009
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2009
1	Transcription Factors (Transcription Factor)IBA 12/2009
1	cytochrome P-450 CYP2C subfamilyIBA 05/2009
1	Messenger RNA (mRNA)IBA 05/2009
1	Cytochrome P-450 CYP2C8IBA 05/2009
1	Cytochrome P-450 CYP2C9IBA 05/2009
1	Cytochrome P-450 CYP2C19IBA 05/2009
1	Endothelin-Converting EnzymesIBA 01/2007
1	Endothelins (Endothelin)IBA 01/2007
1	Thrombin FDA Link 01/2005
1	AnticoagulantsIBA 01/2004
1	coumarinIBA 01/2004
1	Phenprocoumon (Liquamar)FDA Link 01/2004

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 10/2011 - 05/2009
2	Therapeutics 11/2018 - 05/2009
1	Intramuscular Injections 11/2017
1	Off-Label Use 03/2004